AERIE PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Aerie Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2022.
Aerie Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2022 was -$26.7M, a 17.6% increase year-over-year.
Aerie Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2022 was -$26.7M, a 80% increase year-over-year.
Aerie Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$46.4M, a 70.2% increase from 2020.
Aerie Pharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$156M, a 17% increase from 2019.
Aerie Pharmaceuticals Inc annual Operating Income (Loss) for 2019 was -$187M, a 10.6% increase from 2018.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2022	-$26.7M	-$26.7M	+$5.7M	+17.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-04
Q2 2022	-$32.4M	-$18.1M	+$13.4M	+42.4%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-05
Q1 2022	-$45.8M	-$33.6M	+$576K	+1.68%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-06
Q4 2021	-$46.4M	$51.7M	+$87.3M		Oct 1, 2021	Dec 31, 2021	10-K	2022-02-25
Q3 2021	-$134M	-$32.4M	+$1.23M	+3.66%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-04
Q2 2021	-$135M	-$31.5M	+$11.1M	+26%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	-$146M	-$34.2M	+$9.72M	+22.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06
Q4 2020	-$156M	-$35.6M	+$14.3M	+28.7%	Oct 1, 2020	Dec 31, 2020	10-K	2022-02-25
Q3 2020	-$170M	-$33.6M	+$9.72M	+22.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-05
Q2 2020	-$180M	-$42.6M	+$3.52M	+7.64%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	-$183M	-$43.9M	+$4.21M	+8.75%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	-$187M	-$49.9M	+$1.99M	+3.83%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-25
Q3 2019	-$189M	-$43.3M	+$18M	+29.4%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-06
Q2 2019	-$207M	-$46.1M	+$9.61M	+17.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-07
Q1 2019	-$217M	-$48.2M	-$7.36M	-18%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$210M	-$51.9M	+$8.39M	+13.9%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-26
Q3 2018	-$218M	-$61.3M	-$29.2M	-90.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	-$189M	-$55.7M	-$27.9M	-101%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	-$161M	-$40.8M	-$15.4M	-60.4%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	-$146M	-$60.3M	-$31.6M	-110%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-24
Q3 2017	-$114M	-$32.2M	-$8.87M	-38%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07
Q2 2017	-$105M	-$27.8M	-$5.08M	-22.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	-$100M	-$25.4M	-$3.32M	-15%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-09
Q4 2016	-$96.9M	-$28.8M	-$8.81M	-44.1%	Oct 1, 2016	Dec 31, 2016	10-K	2017-03-09
Q3 2016	-$88.1M	-$23.3M	-$5.95M	-34.3%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-09
Q2 2016	-$82.1M	-$22.7M	-$4.56M	-25.2%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-03
Q1 2016	-$77.6M	-$22.1M	-$2.47M	-12.6%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-03
Q4 2015	-$75.1M	-$20M	-$3.98M	-24.9%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-09
Q3 2015	-$71.1M	-$17.4M	-$4.19M	-31.8%	Jul 1, 2015	Sep 30, 2015	10-K	2017-03-09
Q2 2015	-$66.9M	-$18.1M	-$6.29M	-53.1%	Apr 1, 2015	Jun 30, 2015	10-K	2017-03-09
Q1 2015	-$60.6M	-$19.6M	-$10.7M	-119%	Jan 1, 2015	Mar 31, 2015	10-K	2017-03-09
Q4 2014	-$50M	-$16M	$0	0%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-02
Q3 2014	-$50M	-$13.2M	$0	0%	Jul 1, 2014	Sep 30, 2014	10-K	2016-03-02
Q2 2014	-$50M	-$11.8M	$0	0%	Apr 1, 2014	Jun 30, 2014	10-K	2016-03-02
Q1 2014	-$50M	-$8.98M	$0	0%	Jan 1, 2014	Mar 31, 2014	10-K	2016-03-02
Q4 2013	-$50M	-$16M	-$9.22M	-137%	Oct 1, 2013	Dec 31, 2013	10-K	2015-02-27
Q3 2013	-$40.7M	-$13.2M	-$7.49M	-132%	Jul 1, 2013	Sep 30, 2013	10-K	2015-02-27
Q2 2013	-$33.3M	-$11.8M	-$6.73M	-132%	Apr 1, 2013	Jun 30, 2013	10-K	2015-02-27
Q1 2013	-$26.5M	-$8.98M	-$4.36M	-94.4%	Jan 1, 2013	Mar 31, 2013	10-K	2015-02-27
Q4 2012	-$22.2M	-$6.75M			Oct 1, 2012	Dec 31, 2012	10-K	2015-02-27
Q3 2012		-$5.69M			Jul 1, 2012	Sep 30, 2012	10-K	2015-02-27
Q2 2012		-$5.11M			Apr 1, 2012	Jun 30, 2012	10-K	2015-02-27
Q1 2012		-$4.62M			Jan 1, 2012	Mar 31, 2012	10-K	2015-02-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.